Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells - PubMed (original) (raw)

doi: 10.1016/j.stem.2012.05.019.

Kazutoshi Takahashi, Karen Leung, Aki Okada, Megumi Narita, N Alice Yamada, Kirsten E Eilertson, Peter Tsang, Shiro Baba, Mark P White, Salma Sami, Deepak Srivastava, Bruce R Conklin, Barbara Panning, Shinya Yamanaka

Affiliations

Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells

Kiichiro Tomoda et al. Cell Stem Cell. 2012.

Abstract

Female human induced pluripotent stem cell (hiPSC) lines exhibit variability in X-inactivation status. The majority of hiPSC lines maintain one transcriptionally active X (Xa) and one inactive X (Xi) chromosome from donor cells. However, at low frequency, hiPSC lines with two Xas are produced, suggesting that epigenetic alterations of the Xi occur sporadically during reprogramming. We show here that X-inactivation status in female hiPSC lines depends on derivation conditions. hiPSC lines generated by the Kyoto method (retroviral or episomal reprogramming), which uses leukemia inhibitory factor (LIF)-expressing SNL feeders, frequently had two Xas. Early passage Xa/Xi hiPSC lines generated on non-SNL feeders were converted into Xa/Xa hiPSC lines after several passages on SNL feeders, and supplementation with recombinant LIF caused reactivation of some of X-linked genes. Thus, feeders are a significant factor affecting X-inactivation status. The efficient production of Xa/Xa hiPSC lines provides unprecedented opportunities to understand human X-reactivation and -inactivation.

Copyright © 2012 Elsevier Inc. All rights reserved.

PubMed Disclaimer

Figures

Figure 1

Figure 1. X-Linked Genes Are Highly Expressed in Female hiPSC Lines

(A and D) Experimental design to generate hiPSC lines from H9 ESCs (A) and from hFibs (D). The X-inactivation status of the each cell line is also shown. The characterizations of the hiPSC lines are shown in Figure S1 and Table S1. (B and E) Heat maps of relative expression levels of the X-linked genes. All cell lines were cultured in identical conditions. RNA was extracted from H9r iPSC lines at p3 and female hiPSC lines from hFibs at >p15. (C) Percentage of all X-linked genes (probes) that are up-regulated (red) or down-regulated (green) by more than 1.5-fold in the H9r iPSC lines and female (Xa/Xi) hESC lines (average data among ESI03, H9-reporter and H9) or the male (XY) ES H1 cell line. (F) Gene expression ratios on the genome. The expression ratios between female hESC (average data among ESI03, H7, H9 and H9-reporter) and hiPSC (average data among K-3F-1, K-3F-2 and 3S-5F-4) lines are plotted on human genome. Blue bars indicate where each gene maps. Blue bars above the red midline show highly expressed genes in the hESC lines. Blue bars below the midline show highly expressed genes in the hiPSC lines. The height of bars indicates the expression ratio of each gene. Chromosome numbers are shown on top of the diagram. The Y chromosome is excluded in this assay. The X chromosome is expanded in the inset.

Figure 2

Figure 2. Two Xs Are Active in Female hiPSCs

(A) RNA FISH for PGK1 (green) and XIST (red) in hESCs and hiPSCs derived on SNLs. (B) Graph showing the proportion of cells with 0, 1, or 2 sites of PGK1 nascent mRNA accumulation in Xa/Xi hESC (ESI03) and two female hiPSC (K-3F-2 and 3S-5F-4) lines. (C) Relative expression levels of XIST. The expression levels of XIST were extracted from microarray data sets. The male ESC line H1 is used for normalization. Female fibroblasts (hFib) from which the hiPSC lines were generated and Xa/Xi hESCs (ESI03) served as controls. (D) Immuno-FISH. Representative images for localization of RNA polymerase II (RNA polII) (green) and X chromosomes (red) in the indicated cell lines. Arrows show regions depleted of staining for RNA polII in which one of two X chromosomes localizes. The percentage of cells in which no RNA polll exclusion from an X was observed is inset. (E) WDR44 expression in the indicated cell lines was determined by RT-qPCR (left graph). The expression values in the H9-reporter and expression levels of GAPDH were used for normalization. Error bars are standard deviations. The right bar graph shows the percentage of clones that contain T or C at the same position in WDR44 RNA in the indicated cell lines. Five H9-reporter and six H9r-3F-2 clones were sequenced. (F) Methylation patterns of the WDR44 promoter in the indicated cell lines. Each circle denotes a CpG sequence in the promoter region. Black circles, methylated CpGs; white circles, unmethylated CpGs; gray circles, mutated CpGs. Each row for each cell line shows each sequenced clone for the cell lines. (G) Each dot shows the expression ratio between X-linked genes and autosomal genes from each cell line. In left three lanes, deposited microarray data sets for cell lines in which X-inactivation status was already examined are used, and the X/A ratios are plotted as controls. The remaining lanes show X/A ratios from the same lines used in Figure 1. The X/A ratios are also shown in Table S1. (H) X/A ratios from undifferentiated (Undiff) and differentiated (Diff) hESCs and hiPSCs, (each color dot represents a single cell line before and after differentiation) and primary human endothelial cells from biopsy (Primary; red, purple = female, green = male). The X/A ratios from the undifferentiated hESCs and hiPSCs were also used in Figure 1G. (I) RNA FISH for XIST (red) and PGK1 (green) in endothelial cells differentiated from indicated Xa/Xa hiPSC lines. Undifferentiated Xa/Xi hESC line ESI03 and Xa/Xa hiPSC line K-3F-2 serve as controls. (J) Graph showing the proportion of cells exhibiting 0, 1 or 2 sites of nascent PGK1 mRNA accumulation in undifferentiated (K-3F-2; left) and differentiated (K-3F-2 and 3S-5F-4) hiPSCs. 5–15% of differentiated cells exhibit tetraploidy, similar to the proportion of these cells that exhibit two sites of PGK1 RNA accumulation.

Figure 3

Figure 3. Prolonged Culture Promotes X-Reactivation when Propagated on SNL Feeders

(A) X/A ratios from hFib-derived female hiPSC lines at p5 or > p15. Cell lines were generated on SNLs or on non-SNLs. X/A ratios from hiPSC lines in which X-inactivation status was further examined in Figure 3 by FISH and/or SNP sequencing are shown in green, including three cell lines used in Figures 1 and 2. Those examined in Figure 4 are shown in orange. X/A ratios from deposited Xa/Xi and Xa/Xa cell lines are shown in red. Cell lines above the upper black line in the graph have a predicted probability of at least 0.95 of being Xa/Xa, while those below the lower black line have a predicted probability of at least 0.95 of being Xa/Xi or a 0.05 probability of being Xa/Xa (see more details in Figure S2 and EXTENDED EXPERIMENTAL PROCEDURES). The X/A ratios are also shown in Table S1. (B) Graph showing the proportion of cells exhibiting 0, 1 or 2 sites of nascent PGK1 mRNA accumulation in Xa/Xi hESC (ESI03) and three hiPSC lines (K-3F-2, 201B7 and 923S3) on SNLs at > p15. X/A ratios from indicated lines are also shown. (C) Relative expression levels of XIST and NANOG. RNA from the three hiPSC lines (K-3F-1, K-3F-2 and 3S-5F-4) was extracted at indicated passage number and analyzed by RT-qPCR. NANOG was used as a pluripotency marker. The Xa/Xi hESC line (ESI03) and female fibroblasts (hFib) from which the hiPSCs were generated served as controls. The _y_-axis is in logarithmic scale. Expression values of XIST in 3S-5F-4 at p24 and of NANOG in hFib were set as 1.0. (D) SNP sequencing of two X-linked genes (TSPAN6 and FRMPD4) in one hiPSC line K-3F-2 on SNLs at p3 and p24. Arrows show position of SNPs. (E) RNA FISH for PGK1 (green) and XIST (red) in hiPSCs derived on hFibs. The hiPSC line 297C1 contains a mixed population of cells that do and do not express XIST. (F) Graph showing the proportion of cells with 0, 1, or 2 sites of PGK1 nascent mRNA accumulation in three hiPSC lines generated and cultured on non-SNLs at > p12. X/A ratios are included beneath the graph.

Figure 4

Figure 4. SNLs Have a Role in X-Reactivation in Female hiPSCs

(A) Diagram outlining experimental design. Related experiments are also shown in Figure S3. (B and C) X/A ratios of hiPSC lines generated on non-SNLs and cultured as in Figure 4A. “Before” indicates ratios at p9 (B) and p3 (C), and “After” indicates at >p15 under the conditions indicated in Figure 4A. According to our model, cell lines above the upper black line in the graph have a 0.95 probability of being Xa/Xa, those below the lower black line have a 0.95 probability of being Xa/Xi. (D and F) Normalized XIST expression in hiPSCs before and after transfer to SNLs (D) or before and after transfer to rLIF (F). (E and H) SNP sequencing for FRMPD4 and TSPAN6 in hiPSCs before (p5) and after transfer to SNLs (p15) (E) or p15 hiPSCs on MEFs or MEFs plus rLIF (H). The hiPSC line 923M3 exhibits some bi-allelic expression of both genes at p5 on MEFs, consistent with both genes escaping X-inactivation at low frequency (Carrel and Willard, 2005). (G) Graph showing the proportion of cells with 0, 1, or 2 sites of PGK1 nascent mRNA accumulation in indicated conditions. (I) X-Linked gene expression ratios plotted on the X. The probe locations are shown under the X diagram (note that many regions of the X do not have probes). The ratios of SNL hiPSCs and MEF hiPSCs (top bar chart) or between MEF plus rLIF hiPSCs and MEF hiPSCs (bottom bar chart) in hiPSC 923M2 are shown as bar charts. Each blue bar shows ratios for each gene analyzed. Blue bars above the orange line show up regulated genes in SNL hiPSCs or MEF plus rLIF hiPSCs compared with MEF hiPSCs, and below the orange line show down regulated genes. Line labeled (a) indicates a region of the X where gene expression on MEFs and MEFs plus rLIF is comparable, (b) indicates a region where genes are up-regulated to a similar extent on SNLs and MEFs plus rLIF, and (c) indicates a region where genes are up-regulated to a lesser degree on MEFs plus rLIF than on SNLs. Location of FRMPD4 is indicated with an arrowhead.

Similar articles

Cited by

References

    1. Blanchard F, Raher S, Duplomb L, Vusio P, Pitard V, Taupin JL, Moreau JF, Hoflack B, Minvielle S, Jacques Y, et al. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. The Journal of biological chemistry. 1998;273:20886–20893. - PubMed
    1. Brown CJ, Willard HF. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature. 1994;368:154–156. - PubMed
    1. Bruck T, Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res. 2011;6:187–193. - PubMed
    1. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature. 2005;434:400–404. - PubMed
    1. Cheung AY, Horvath LM, Grafodatskaya D, Pasceri P, Weksberg R, Hotta A, Carrel L, Ellis J. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 2011;20:2103–2115. - PMC - PubMed

Publication types

MeSH terms

Grants and funding

LinkOut - more resources